ENSYSCE BIOSCIENCES, INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $27.59 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-03-30
- ENSYSCE BIOSCIENCES, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $27.59K, a 6113.29% increase from fiscal 2024.
- ENSYSCE BIOSCIENCES, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $444.00.
- ENSYSCE BIOSCIENCES, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $48.03K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $27.59K 10-K · filed 2026-03-30 |
| 2024-12-31 | $444.00 10-K · filed 2026-03-30 |
| 2022-12-31 | $48.03K 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |